Skip to content
Home/Companies/HealthTech/Instem
Instem

Instem

HealthTech·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Instem?

Instem is an American HealthTech company, currently owned by ARCHIMED since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQUnited States
SectorHealthTech
Websitewww.instem.com

More from MED Platform II

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
· 2026
ARK Diagnostics
Active
MedTechUS· 2025
Symbio
Symbio
Active
ClimateTechUS· 2023
WiQo
WiQo
Active
HealthTechItaly· 2023
Corealis
Corealis
Active
PharmaCanada· 2022
Natus
Natus
Active
MedTechUS· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Instem?

Instem is currently owned by ARCHIMED, through MED Platform II, since 2023.

When did ARCHIMED acquire Instem?

ARCHIMED acquired Instem in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue